Connor, Clark & Lunn Investment Management (CC&L)
PTLA

Connor, Clark & Lunn Investment Management (CC&L)’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio PTLA Stock Details PTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-6,300
Closed -$269K – 892
2015
Q3 		$269K Sell
6,300
-2,800
-31% -$135K ﹤0.01% 609
2015
Q2 		$415K Sell
9,100
-4,000
-31% -$161K ﹤0.01% 453
2015
Q1 		$497K Sell
13,100
-3,000
-19% -$103K ﹤0.01% 393
2014
Q4 		$456K Buy
+16,100
New +$448K ﹤0.01% 402

Other funds holding PTLA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L)'s PTLA Position: Q4 2015 in Review

Connor, Clark & Lunn Investment Management (CC&L) sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q4 2015, closing a stake of 6,300 shares — an estimated $269K sold.

Connor, Clark & Lunn Investment Management (CC&L) first reported a position in PTLA in Q4 2014 and held it in 4 quarters. The position peaked at $497K in Q1 2015. 190 funds tracked by Wall St. Rank hold PTLA as of Q4 2015.

  • Connor, Clark & Lunn Investment Management (CC&L) reported no remaining Portola Pharmaceuticals, Inc. position as of Q4 2015 after selling out during the quarter.
  • Connor, Clark & Lunn Investment Management (CC&L) sold 6,300 Portola Pharmaceuticals, Inc. shares in Q4 2015, an estimated $269K.
  • Connor, Clark & Lunn Investment Management (CC&L) first reported a position in Portola Pharmaceuticals, Inc. in Q4 2014 and held it in 4 quarters.
  • Connor, Clark & Lunn Investment Management (CC&L)'s Portola Pharmaceuticals, Inc. position peaked at $497K in Q1 2015.
  • 190 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q4 2015.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q4 2015, filed 11 Feb 2016.